Talk:Welcome to GDPRhub: Difference between revisions
Krystalbeily (talk | contribs) (→1-MethylpseudoUridine: new section) |
Krystalbeily (talk | contribs) (→MA-PEG4-vc-PAB-DMEA-duocarmycin DM: new section) |
||
Line 67: | Line 67: | ||
N1-methyl-pseudoUridine ([https://www.bocsci.com/product/1-methylpseudouridine-cas-13860-38-3-207673.html 1-Methylpseudouridine]), a methylpseudoUridine, outperforms 5 mC and 5 mC/N1-methyl-pseudoUridine in translation. N1-methyl-pseudoUridine in mRNA enhances translation through eIF2α-dependent and independent mechanisms by increasing ribosome density. | N1-methyl-pseudoUridine ([https://www.bocsci.com/product/1-methylpseudouridine-cas-13860-38-3-207673.html 1-Methylpseudouridine]), a methylpseudoUridine, outperforms 5 mC and 5 mC/N1-methyl-pseudoUridine in translation. N1-methyl-pseudoUridine in mRNA enhances translation through eIF2α-dependent and independent mechanisms by increasing ribosome density. | ||
== MA-PEG4-vc-PAB-DMEA-duocarmycin DM == | |||
[https://adc.bocsci.com/product/ma-peg4-vc-pab-dmea-duocarmycin-dm-335116.html MA-PEG4-vc-PAB-DMEA-duocarmycin DM] is a drug-linker conjugate for ADC by using Duocarmycin DM (a potent antitumor antibiotic), linked via MA-PEG4-vc-PAB-DMEA. |
Revision as of 02:31, 18 September 2023
GDPR Knowledge column - Desktop - image linkfix
To fix links on symbols "GDPR Commentary" & "DPAs & Procedures", replace this:
{| class="desktop-only" style="background-color:#f8f9fa; width:100%;" border="0" ! colspan="3" style="text-align: center; background-color:#9c0a7d; color:#ffffff; width=50%; padding: 5px;" |GDPR Decision Database ! colspan="3" style="text-align: center; background-color:#9c0a7d; color:#ffffff; width=50%; padding: 5px;" |GDPR Knowledge |- | colspan="3" |Here you can find 300+ national GDPR decisions, arranged by GDPR Article, DPAs or the relevant Courts. | colspan="3" |Here you can find a commentary on the first 21 GDPR Articles, profiles on 32 DPAs and profiles on 32 GDPR jurisdictions. |- | style="text-align: center; vertical-align: top; border: 0px; padding: 5px;" | [[File:Icon gdpr.png|center|100px|link=:Category:Decisions on GDPR Articles|alt="text"]] [[:Category:Decisions on GDPR Articles|Decisions by Articles]] | style="text-align: center; vertical-align: top; border: 0px; padding: 5px;" | [[File:Icon dpa.png|center|100px|link=:Category:DPA Decisions|alt=]] [[:Category:DPA Decisions|DPA Decisions]] | style="text-align: center; vertical-align: top; border: 0px; padding: 5px;" | [[File:Icon court.png|center|100px|link=:Category:Court Decisions|alt=]] [[:Category:Court Decisions|Court Decisions]] | style="text-align:center; vertical-align:top; border: 0px; padding: 5px;" |[[File:Icon gdpr info 2.png|alt="GDPR Commentary"|center|100x100px]][[Article 1 GDPR|GDPR Commentary]] | style="text-align:center; vertical-align:top; border: 0px; padding: 5px;" |[[File:Icon dpa procedure 1.png|alt="DPAs & Procedures"|center|100x100px]][[:Category:DPA|DPAs & Procedures]] | style="text-align:center; vertical-align:top; border: 0px; padding: 5px;" | [[File:Icon jurisdictions.png|center|100px|link=:Category:Country Overview|alt="Jurisdictions"]] [[:Category:Country Overview|Member State Law]] |}
with this:
{| class="desktop-only" style="background-color:#f8f9fa; width:100%;" border="0" ! colspan="3" style="text-align: center; background-color:#9c0a7d; color:#ffffff; width=50%; padding: 5px;" |GDPR Decision Database ! colspan="3" style="text-align: center; background-color:#9c0a7d; color:#ffffff; width=50%; padding: 5px;" |GDPR Knowledge |- | colspan="3" |Here you can find 300+ national GDPR decisions, arranged by GDPR Article, DPAs or the relevant Courts. | colspan="3" |Here you can find a commentary on the first 21 GDPR Articles, profiles on 32 DPAs and profiles on 32 GDPR jurisdictions. |- | style="text-align: center; vertical-align: top; border: 0px; padding: 5px;" | [[File:Icon gdpr.png|center|100px|link=:Category:Decisions on GDPR Articles|alt="text"]] [[:Category:Decisions on GDPR Articles|Decisions by Articles]] | style="text-align: center; vertical-align: top; border: 0px; padding: 5px;" | [[File:Icon dpa.png|center|100px|link=:Category:DPA Decisions|alt=]] [[:Category:DPA Decisions|DPA Decisions]] | style="text-align: center; vertical-align: top; border: 0px; padding: 5px;" | [[File:Icon court.png|center|100px|link=:Category:Court Decisions|alt=]] [[:Category:Court Decisions|Court Decisions]] | style="text-align:center; vertical-align:top; border: 0px; padding: 5px;" |[[File:Icon gdpr info 2.png|link=Article 1 GDPR|alt="GDPR Commentary"|center|100x100px]][[Article 1 GDPR|GDPR Commentary]] | style="text-align:center; vertical-align:top; border: 0px; padding: 5px;" |[[File:Icon dpa procedure 1.png|link=:Category:DPA|alt="DPAs & Procedures"|center|100x100px]][[:Category:DPA|DPAs & Procedures]] | style="text-align:center; vertical-align:top; border: 0px; padding: 5px;" | [[File:Icon jurisdictions.png|center|100px|link=:Category:Country Overview|alt="Jurisdictions"]] [[:Category:Country Overview|Member State Law]] |}
kind regards --MilesTeg (talk)
Thesis about the GDPR - health data - workplace
Hello everyone, I am a law student writing a thesis about how the GDPR affects the processing of health data in the workplace. I am kind of lost because I cannot pinpoint about what I should exactly write about. Is there anyone who could help me? I am a EU based student.
N1-MethylpseudoUridine-5'-Triphosphate
N1-MethylpseudoUridine-5'-Triphosphate is a modified NTP for incorporation into messenger RNAs (mRNA) using T7 RNA Polymerase. Incorporation of N1-methylpseudouridine can reduce the immunogenicity of the resulting mRNA.
1-MethylpseudoUridine
N1-methyl-pseudoUridine (1-Methylpseudouridine), a methylpseudoUridine, outperforms 5 mC and 5 mC/N1-methyl-pseudoUridine in translation. N1-methyl-pseudoUridine in mRNA enhances translation through eIF2α-dependent and independent mechanisms by increasing ribosome density.
MA-PEG4-vc-PAB-DMEA-duocarmycin DM
MA-PEG4-vc-PAB-DMEA-duocarmycin DM is a drug-linker conjugate for ADC by using Duocarmycin DM (a potent antitumor antibiotic), linked via MA-PEG4-vc-PAB-DMEA.